Zydus Executive and Leadership Team

Mangesh Vaze, the President, Api Business at Zydus, directs the global manufacturing and supply chain operations for active pharmaceutical ingredients. Overseeing complex chemical synthesis processes, the President, Api Business ensures compliance with stringent international regulatory standards across facilities in India and the United States. This leadership role involves optimizing production efficiency to support the broader pharmaceutical portfolio. By managing large-scale procurement and distribution networks, Mangesh Vaze maintains the consistent availability of critical raw materials for finished dosage forms. The President, Api Business coordinates with research teams to integrate new chemical entities into the manufacturing pipeline, thereby accelerating time-to-market for essential medications. Through rigorous quality control and process engineering, Vaze secures the operational integrity of the API division, directly contributing to the company's competitive position in regulated global markets.

Harish Sadana, the President Corporate Matters at Zydus, manages the legal, regulatory, and governance frameworks that underpin the company's global operations. Overseeing corporate compliance across diverse jurisdictions including Brazil and Europe, the President Corporate Matters ensures alignment with international pharmaceutical laws. This leadership role involves navigating complex legal landscapes to protect intellectual property and facilitate cross-border business expansion. By advising the board on strategic risk management, Harish Sadana safeguards the organizational reputation and financial stability. The President Corporate Matters coordinates with external legal counsel and regulatory bodies to maintain the highest standards of corporate conduct. Through the implementation of robust governance policies, Sadana supports the sustainable growth of the enterprise, ensuring that all business activities adhere to ethical guidelines while fostering transparency across the entire global footprint of the organization.

Kapil Maithal, the President, Vaccines and Diagnostics at Zydus, leads the research, development, and commercialization of immunological products and diagnostic tools. Overseeing advanced laboratory facilities, the President, Vaccines and Diagnostics drives innovation in preventative medicine to address unmet clinical needs. This leadership role involves managing clinical trial programs and securing regulatory approvals for new vaccine candidates. By collaborating with global health organizations, Kapil Maithal expands the reach of diagnostic solutions into emerging markets. The President, Vaccines and Diagnostics coordinates with manufacturing teams to scale production for high-demand immunization campaigns. Through the application of cutting-edge biotechnology, Maithal enhances the company's portfolio, ensuring that Zydus remains at the forefront of medical science. This focus on specialized healthcare products directly supports the mission of improving patient outcomes through proactive disease management and rapid diagnostic capabilities.

Nitinkumar Parekh, the President (Special Projects) at Zydus, executes high-priority strategic initiatives designed to enhance operational efficiency and market penetration. Overseeing cross-functional teams, the President (Special Projects) identifies opportunities for business process optimization and infrastructure development. This leadership role involves managing large-scale capital investments and integrating new technologies into existing manufacturing workflows. By analyzing market trends and competitive dynamics, Nitinkumar Parekh develops actionable plans to improve the company's agility in the pharmaceutical sector. The President (Special Projects) coordinates with other executive leaders to ensure that these initiatives align with the long-term growth objectives of the organization. Through the successful execution of complex projects, Parekh drives significant improvements in productivity and cost management, ultimately strengthening the company's ability to deliver high-quality pharmaceutical products to a diverse global customer base.

Dr.Amrut Naik, the President at Zydus, oversees the clinical research and development functions that drive the company's therapeutic pipeline. Managing a team of scientists and medical experts, the President ensures that all research activities meet rigorous scientific and ethical standards. This leadership role involves designing clinical study protocols and interpreting data to support the development of new pharmaceutical products. By fostering partnerships with academic institutions and research organizations, Dr.Amrut Naik accelerates the translation of laboratory discoveries into clinical applications. The President coordinates with regulatory affairs teams to facilitate the submission of new drug applications across international markets. Through the application of deep medical expertise, Naik ensures that the company's product development strategy remains focused on high-impact therapeutic areas, thereby enhancing the overall value of the pharmaceutical portfolio and supporting the company's commitment to medical innovation.

Kacharu Toshniwal, the President at Zydus, directs the operational management of manufacturing facilities to ensure consistent product quality and supply chain reliability. Overseeing production schedules and resource allocation, the President maintains the efficiency of the company's extensive manufacturing network. This leadership role involves implementing lean manufacturing principles and continuous improvement programs to reduce waste and optimize output. By monitoring performance metrics across various sites, Kacharu Toshniwal ensures that all operations adhere to global quality standards and safety regulations. The President coordinates with logistics and distribution teams to manage the flow of finished goods to regulated markets worldwide. Through the application of operational excellence, Toshniwal supports the company's ability to meet global demand for pharmaceutical products, ensuring that the manufacturing infrastructure remains a robust foundation for the organization's ongoing commercial success.

Rishikesh Raval, the Group President, Human Resources & Corporate Communications at Zydus, manages the organizational culture, talent acquisition, and internal/external messaging strategies. Overseeing global workforce development, the Group President, Human Resources & Corporate Communications ensures that the company attracts and retains top-tier talent to support its pharmaceutical mission. This leadership role involves designing comprehensive training programs and performance management systems that align with corporate goals. By directing corporate communications, Rishikesh Raval shapes the public perception of the company and maintains transparent engagement with stakeholders. The Group President, Human Resources & Corporate Communications coordinates with leadership across all departments to foster an inclusive and high-performance work environment. Through the integration of human capital strategy and effective communication, Raval strengthens the organizational identity, ensuring that the company's values are reflected in every aspect of its global operations.